Meet a 2019 M2D2 Challenge Finalist: CardioCorX

Randy Werneth of CardioCorX

Randy Werneth, CEO and President of CardioCorX



Introducing CardioCorX, one of 21 MedTech startups chosen as finalists in the 8th annual M2D2 $200K Challenge. We spoke with CEO and President, Randy Werneth, who shared the story of their innovation.

CardioCorX was chosen for their development of a simple integrative medical approach for patients suffering from atrial fibrillation with or without heart failure.

Continue reading

Meet a 2019 M2D2 Challenge Finalist: Respirix

From left to right: Daniel Burnett, Founder and Chairman, Evan Luxon, Scientific co-founder, and Eric Kriegstein, CEO.

Daniel Burnett, Evan Luxon, and Eric Kriegstein of Respirix.



Introducing Respirix, one of 21 medtech startups chosen as finalists in the 8th annual M2D2 $200K Challenge. We spoke with CEO Eric Kriegstein who shared the story of their innovation.

Respirix is developing a hardware and software platform to change the paradigm for non-invasively monitoring, and managing, patient health.

Continue reading

M2D2 Announces 2019 $200K Challenge Finalists!

Winners of the 2019 M2D2 $200K Challenge will be announced April 10, 2019.21 finalists have been selected from over 150 applicants for the 8th Annual M2D2 $200K Challenge. This year’s participation sets a new record for the competition!

LOWELL, Massachusetts – The University of Massachusetts Medical Device Development Center (M2D2) today announced the finalists in its 8th annual $200K Challenge after reviewing a record-setting 150+ applications. Continue reading

M2D2 Welcomes New Resident Company: Nuclease Probe Technologies

nuclease-probe-tech-logoNuclease Probe Technologies has raised $500,000 from Breakout Labs to Support Development of Rapid Antibiotic Susceptibility Testing for Bloodstream Infections. 

With this funding, NPT will commence operations at M2D2 in Lowell. We’re thrilled to welcome the new resident company and look forward to aiding them with the tools and space needed for further development! Continue reading

Hologic Announces Corporate Sponsorship of M2D2

Marlborough, MA — Hologic, Inc. is the newest sponsor of the Massachusetts Medical Device Development Center (M2D2). M2D2 is a University of Massachusetts Lowell and Medical School-affiliated incubator for early stage startups that runs the annual $200K Challenge international competition to showcase innovative medical device, diagnostic, and biotech companies. Continue reading

Deshpande Foundation announces support for India-based M2D2 $200K Challenge finalists

The Deshpande Foundation will pay travel expenses for India-based startups who are named M2D2 $200K Challenge finalists.The M2D2 $200K Challenge has always drawn entrants from around the world. This year, a Challenge sponsor is giving India-based innovators an extra-generous incentive to participate.

The Deshpande Foundation has announced that they will fund up to three $200K Challenge finalist teams to travel from India to M2D2 from approximately March 10th to April 10th. Continue reading

Startups: Map your Path to Venture Financing at our Happy Hour on January 30.

Make your Venture Financing Plan at the M2D2 Happy Hour on January 30.Venture financing is every entrepreneur’s goal— so every entrepreneur needs a plan to get his or her startup to the venture financing stage. That’s why M2D2 is hosting an informative happy hour: Simplifying Venture Financing: What You Need To Know, after work on Wednesday, January 30. For knowledge-gathering and great networking (plus food and drinks), it’s a don’t-miss event for Boston-area life sciences startups. Continue reading